Robotic cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: is there a benefit?

While the burden of disease was a main driver for selection of patients for robotic approach, the difference in PCI between the groups did not reach statistical significance.

also in 111,027 other papers